Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy

Eye

Volumn 22, Issue 4, 2008, Pages 528-533

  Fong, K C S ^a   Thomas, D ^a   Amin, K ^a   Inzerillo, D ^a   Horgan, S E ^a  

^a KINGSTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; VERTEPORFIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE STUDY; CHOROID DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; PHOTODYNAMIC THERAPY; PUNCTATE INNER CHOROIDOPATHY; RETINA ANGIOGRAPHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

EID: 42449094051     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702688     Document Type: Article

References (27)

1. Watzke RC, Packer AJ, Folk JC, Benson WE, Burgess D, Ober RR. Punctate inner choroidopathy. Am J Ophthalmol 1984; 98: 572-584.
2. Brown Jr J, Folk JC, Reddy CV, Kimura AE. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy and the diffuse retinal fibrosis syndrome. Ophthalmology 1996; 103: 1100-1105.
3. Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ et al. The use of corticosteroids for choroidal neovascularisation in young patients. Eye 1998; 12(Part 2): 266-272.
4. Cummings HL, Rehmar AJ, Wood WJ, Isernhagen RD. Long-term results of laser treatment in ocular histoplasmosis syndrome. Arch Ophthalmol 1995; 113: 465-468.
5. Eckstein M, Wells JA, Aylward B, Gregor Z. Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye 1998; 12: 775-780.
6. Macular Photocoagulation Study Group. Persistent and recurrent neovascularisation after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol 1991; 107: 344-352.
7. Melberg NS, Thomas MA, Dickinson JD, Valluri S. Managing recurrent neovascularisation after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 1996; 103: 1064-1067.
8. Treatment of Agre-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin One year results of two randomized clinical trials-TAP report 1. Arch Ophthalmol 1999; 117: 1329-1345.
9. Chatterjee S, Gibson JM. Photodynamic therapy: A treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 2003; 87: 925-927.
10. Wachtlin J, Heimann H, Behme T, Foerster MH et al. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 2003; 241: 899-906.
11. Leslie T, Lois N, Christopoulou D, Olson JA, Forrester JV et al. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 2005; 89: 147-150.
12. Postelmans L, Pasteels B, Coquelet P, Caspers L, Verougstraete C, Leys A et al. Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Ocul Immunol Inflamm 2005; 13: 361-366.
13. Lim JI, Flaxel CJ, Labree L. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore 2006; 35: 195-198.
14. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: Five year results from randomized clinical trials. Arch Ophthalmol 1991; 109: 1109-1114.
15. Olsen TW, Capone Jr A, Sternberg Jr P, Grossniklaus HE, Martin DF, Aaberg Sr TM et al. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 1996; 103: 2061-2069.
16. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) and Verteporfin In Photodynamic Therapy (VIP) Study Groups. Effects of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration - TAP and VIP Report No. 1. Am J Ophthalmol 2003; 136: 407-418.
17. Dunlop AA, Cree IA, Hague S, Luthert PJ, Lightman S. Multifocal choroiditis: Clinicopathological correlation. Arch Ophthalmol 1998; 116: 801-803.
18. Spaide RF. Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 2006; 141: 149-156.
19. Ciulla TA,Walker JD, Fong DS, Criwell MH. Corticosteroids in posterior segment disease: An update on new delivery systems and new indications. Curr Opin Ophthalmol 2004; 15: 211-220.
20. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998; 341: 309-315.
21. Itaya H, Imaizumi T, Yoshida H, Koyama M, Suzuki S, Satoh K et al. Expression of vascular endothelial growth factor in human monocyte/ macrophages stimulated with lipopolysaccharide. Thromb Haemost 2001; 85: 171-176.
22. Rogers AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002; 134: 566-576.
23. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived growth factor. Invest Ophthalmol Vis Sci 2003; 44: 4473-4490.
24. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005; 112: 301-304.
25. Jonas JB. Intravitreal injection of triamcinolone acetonide.In: Holz FG, Spaide RF (eds). Medical Retina, 1st ed. Springer: Berlin, 2005,pp 143-164.
26. D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger DS, Luna SP et al. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: Twelve-month clinical outcomes. Ophthalmology 2003; 110: 2372-2383, discussion 84-85.
27. Rogers AH, Duker JS, Nichols N, Baker BJ. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003; 110: 1315-1320.